Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,102
Closed -$248K 205
2022
Q3
$248K Buy
1,102
+123
+13% +$29.8K 0.02% 161
2022
Q2
$238K Buy
+979
New +$240K 0.02% 173
2020
Q4
Sell
-1,595
Closed -$405K 156
2020
Q3
$405K Buy
1,595
+417
+35% +$103K 0.03% 112
2020
Q2
$278K Sell
1,178
-3
-0.3% -$684 0.03% 120
2020
Q1
$239K Buy
1,181
+99
+9% +$21.6K 0.03% 122
2019
Q4
$261K Buy
+1,082
New +$239K 0.02% 139
2019
Q2
Sell
-33,345
Closed -$6.33M 150
2019
Q1
$6.33M Sell
33,345
-98,305
-75% -$18.8M 0.53% 52
2018
Q4
$25.6M Buy
131,650
+130,120
+8,505% +$25.4M 2.48% 8
2018
Q3
$317K Buy
+1,530
New +$302K 0.03% 123

Other funds holding AMGN

Cookson Peirce & Co's AMGN Position: Q4 2022 in Review

Cookson Peirce & Co sold out of Amgen (AMGN) in Q4 2022, closing a stake of 1,102 shares — an estimated $248K sold.

Cookson Peirce & Co first reported a position in AMGN in Q3 2018 and held it in 9 quarters. The position peaked at $25.6M in Q4 2018. 2,502 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.

  • Cookson Peirce & Co reported no remaining Amgen position as of Q4 2022 after selling out during the quarter.
  • Cookson Peirce & Co sold 1,102 Amgen shares in Q4 2022, an estimated $248K.
  • Cookson Peirce & Co first reported a position in Amgen in Q3 2018 and held it in 9 quarters.
  • Cookson Peirce & Co's Amgen position peaked at $25.6M in Q4 2018.
  • 2,502 funds tracked by Wall St. Rank held Amgen as of Q4 2022.

Based on Cookson Peirce & Co's 13F filing for Q4 2022, filed 31 Jan 2023.